Evidence map›Paper›PMID 35056889›Full record

ArticleMolecules (Basel, Switzerland)2022

In Vitro Evaluation of the Cytotoxic Effect of

Alexandr N Chernov, Anna Tsapieva, Diana A Alaverdian, Tatiana A Filatenkova, Elvira S Galimova, Mariia Suvorova, Olga V Shamova, Alexander N Suvorov

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Alexandr N ChernovScientific and Educational Center "Molecular Bases of Interaction of Microorganisms and Human", Center for Personalized Medicine, FSBSI Institute of Experimental Medicine, Acad. Pavlov Street, 12, 197376 St. Petersburg, Russia.
Anna TsapievaScientific and Educational Center "Molecular Bases of Interaction of Microorganisms and Human", Center for Personalized Medicine, FSBSI Institute of Experimental Medicine, Acad. Pavlov Street, 12, 197376 St. Petersburg, Russia.ORCID 0000-0001-7878-6339
Diana A AlaverdianDepartment of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Tatiana A FilatenkovaScientific and Educational Center "Molecular Bases of Interaction of Microorganisms and Human", Center for Personalized Medicine, FSBSI Institute of Experimental Medicine, Acad. Pavlov Street, 12, 197376 St. Petersburg, Russia.
Elvira S GalimovaScientific and Educational Center "Molecular Bases of Interaction of Microorganisms and Human", Center for Personalized Medicine, FSBSI Institute of Experimental Medicine, Acad. Pavlov Street, 12, 197376 St. Petersburg, Russia.ORCID 0000-0002-8773-0932
Mariia SuvorovaDisease Systems Immunology, Department of Biotechnology and Biomedicine, Technical University of Denmark, Søltofts Plads 224, DK-2800 Kgs. Lyngby, Denmark.
Olga V ShamovaScientific and Educational Center "Molecular Bases of Interaction of Microorganisms and Human", Center for Personalized Medicine, FSBSI Institute of Experimental Medicine, Acad. Pavlov Street, 12, 197376 St. Petersburg, Russia.
Alexander N SuvorovScientific and Educational Center "Molecular Bases of Interaction of Microorganisms and Human", Center for Personalized Medicine, FSBSI Institute of Experimental Medicine, Acad. Pavlov Street, 12, 197376 St. Petersburg, Russia.
Institute of Experimental Medicine · RUInstitute of Evolutionary Physiology and Biochemistry · RUTechnical University of Denmark · DKUniversity of Siena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain cancer treatment, where glioblastoma represents up to 50% of all CNS malignancies, is one of the most challenging calls for neurooncologists. The major driver of this study was a search for new approaches for the treatment of glioblastoma. We tested live

Indexed as

Antimicrobial Cationic PeptidesCathelicidinsCell SurvivalGliomaNerve Growth FactorStreptococcus pyogenesAnimalsAntineoplastic AgentsBrain NeoplasmsCarboplatinCell Line, TumorDrug SynergismEtoposideHumansAntimicrobial Cationic PeptidesAntineoplastic AgentsCarboplatinCathelicidinsEtoposideNerve Growth Factorcathelicidin family peptideschemotherapycytotoxicityglioma C6human normal fibroblastsLL-37MTT assayNGFPG-1real-time xCELLigence systemStreptococcus pyogenestrypan blue assay

Identifiers

PMID35056889
PMCPMC8779124
OpenAlexW4206746381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.